Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT03644732
Recruiting Observational

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)

NCT03644732 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Grenoble
Phase
Observational
Started
2018-04-05
Last updated
2024-03-19

Condition(s) studied

Refractory EpilepsyFocal Epilepsy

Investigational drug(s) / intervention(s)

SEEG Group

SEEG Group: Visual and quantitative SEEG signal analysis. As available, collection of behavioral and neuropsychological postsurgical data

Study summary

The main objective of MAPCOG\_SEEG is to create a database including brain recordings of cognition performed in clinical routine in patients during the pre-surgical SEEG assessment. This aims to be able to propose the first atlas of human cognition with a high temporal and spatial resolution.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Drug-resistant focal epilepsy * Justified SEEG exploration in the context of presurgical assessment of epilepsy * Written non-opposition to study participation * Intellectual capacities compatible with the compliance in the cognitive tasks Exclusion Criteria: * Major Patient undergoing a legal protection measure or patient deprived of liberty as a result of a judicial or administrative decision * Impossibility of collecting information on exposure (recent arrival in France, foreign language, etc.) * Pregnant women (Contraindication to SEEG exploration)

Primary outcome measure(s)

  • SEEG recordings using functional brain mapping procedure (composite measures) — 3 weeks
    Prospective collection of data from SEEG recordings using functional brain mapping procedure performed in clinical routine during the presurgical assessment of patients with drug-resistant epilepsy. These data are represented by the electroencephalographic activity during the realization of the different cognitive tasks proposed to the patients. Electroencephalographic activity will then be analyzed in terms of Dynamic Spectral Imaging and in terms of high frequency activity (\[50-150Hz\]).

Trial sites (4)

FacilityCityRegionStatus
University Hospital, Grenoble Grenoble France Recruiting
CHRU Nancy Nancy France Recruiting
Hôpital Ste Anne Paris France Recruiting
CHU Rennes Rennes France Recruiting

More University Hospital, Grenoble trials in France

Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders Recruiting
Abdominal Massage After Colon Surgery for Cancer Starting soon
Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy Recruiting
Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease Recruiting
Prospective Cohort Study Evaluating Iron Supplementation in Patients With Altered Iron Status in the Context of Acute Inflammation (CARMI (CARence Martiale & Inflammation)) Starting soon

Other trials for the same condition

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Active, not recruiting
An Open-label Study of XEN1101 in Epilepsy Enrolling by invitation
Efficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG Monitoring Recruiting
Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients Recruiting
Long-term Safety and Tolerability of BHV-7000 Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03644732 on ClinicalTrials.gov ↗ ← All trials in France